Efficacy of bevacizumab plus irinotecan in children with recurrent low-grade gliomas—a Pediatric Brain Tumor Consortium study

Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma

(2012) Eric Bouffet et al.   JOURNAL OF CLINICAL ONCOLOGY

Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium study

(2012) S. Gururangan et al.   NEURO-ONCOLOGY

Long-term efficacy and toxicity of bevacizumab-based therapy in children with recurrent low-grade gliomas

(2012) Eugene I. Hwang et al.   PEDIATRIC BLOOD & CANCER

Quantitative volumetric analysis of conventional MRI response in recurrent glioblastoma treated with bevacizumab

(2011) B. M. Ellingson et al.   NEURO-ONCOLOGY

Vascular endothelial growth factor receptor 2 (VEGFR-2) signalling activity in paediatric pilocytic astrocytoma is restricted to tumour endothelial cells

(2011) A. H. Sikkema et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

Lack of Efficacy of Bevacizumab Plus Irinotecan in Children With Recurrent Malignant Glioma and Diffuse Brainstem Glioma: A Pediatric Brain Tumor Consortium Study

(2010) Sridharan Gururangan et al.   JOURNAL OF CLINICAL ONCOLOGY

Tumour vasculature and angiogenic profile of paediatric pilocytic astrocytoma; is it much different from glioblastoma?

(2010) M. Sie et al.   NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY

VEGF signalling inhibition-induced proteinuria: Mechanisms, significance and management

(2009) Hassane Izzedine et al.   EUROPEAN JOURNAL OF CANCER

The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood

(2009) Michael C. Kruer et al.   JOURNAL OF NEURO-ONCOLOGY

Adverse effects of anticancer agents that target the VEGF pathway

(2009) Helen X. Chen et al.   Nature Reviews Clinical Oncology

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

(2009) Roger J. Packer et al.   PEDIATRIC BLOOD & CANCER

Tumor Angiogenic and Hypoxic Profiles Predict Radiographic Response and Survival in Malignant Astrocytoma Patients Treated With Bevacizumab and Irinotecan

(2008) Sith Sathornsumetee et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

(2008) Julia L. Glade Bender et al.   JOURNAL OF CLINICAL ONCOLOGY